SC 13G Filing

Company

COSCIENS Biopharma Inc.

Filed

June 6, 2024

Accession Number

0001493152-24-022894

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →